Immunotherapy

Keyphrases

Publications

volume 15, number 4, 2023

Jorge Sanchez, Leidy Alvarez, Elizabeth García
Real-world study: drug reduction in children with allergic rhinitis and asthma receiving immunotherapy. Immunotherapy 15 (4) (2023)
Himani Aggarwal, KayOnda Bayo, Yimei Han, Catherine Elizabeth Muehlenbein, Yajun Emily Zhu, Jong Seok Kim
Real-world maintenance therapy and survival outcomes for pembrolizumab plus pemetrexed and platinum for non-small-cell lung cancer in USA. Immunotherapy 15 (4) (2023)
Marine Lhuillier, Magali Brière, Mathieu Artifoni, Marion Chapal, Lucie Peuvrel, Mélanie Saint-Jean
Cemiplimab-induced cytokine-release syndrome: second case reported and review of the literature. Immunotherapy 15 (4) (2023)
Marine Lhuillier, Magali Brière, Mathieu Artifoni, Marion Chapal, Lucie Peuvrel, Mélanie Saint-Jean
Cemiplimab-induced cytokine-release syndrome: second case reported and review of the literature. Immunotherapy 15 (4) (2023)
Hossein Rahavi, Reza Alizadeh Navaei, Mohsen Tehrani
Efficacy of therapies targeting TGF-β in solid tumors: a systematic review and meta-analysis of clinical trials. Immunotherapy 15 (4) (2023)
Guojun Yao, Junping Huang, Qu Zhang, Desheng Hu, Feng Yuan, Guang Han
Excellent response of refractory triple-negative breast cancer to sintilimab plus chemotherapy: a case report. Immunotherapy 15 (4) (2023)
Cliff Molife, Alan Brnabic, Victoria J Stefaniak, Mark A Belger, Kristi Gruver, Jing Voon Chen, Saman Souri, George R Blumenschein
Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer: network meta-analysis. Immunotherapy 15 (4) (2023)

volume 15, number 5, 2023

Pauline Wils, Laurent Peyrin-Biroulet
Etrasimod for the treatment of ulcerative colitis. Immunotherapy 15 (5) (2023)
Xiaoyan Chen, Wenjie Shi
An unusual case of immune-related gastritis in one patient receiving toripalimab therapy. Immunotherapy 15 (5) (2023)
Xiaoyan Chen, Wenjie Shi
An unusual case of immune-related gastritis in one patient receiving toripalimab therapy. Immunotherapy 15 (5) (2023)
Mateus de Oliveira Taveira, Milton José de Barros E Silva, Paula Nicole Vieira Pinto Barbosa
Imaging-calculated splenic volume is associated with response in melanoma patients treated with immunotherapy. Immunotherapy 15 (5) (2023)
Cynthia Yeung, Nicole Relke, David Good, Natasha Satkunam, Mihaela Mates
Antithymocyte globulin for aplastic anemia secondary to pembrolizumab: a case report and review of literature. Immunotherapy 15 (5) (2023)
Cynthia Yeung, Nicole Relke, David Good, Natasha Satkunam, Mihaela Mates
Antithymocyte globulin for aplastic anemia secondary to pembrolizumab: a case report and review of literature. Immunotherapy 15 (5) (2023)
Nicolina Jovanovich, Ahmed Habib, Nu Farrukh Hameed, Lincoln Edwards, Pascal O Zinn
Applications and current challenges of chimeric antigen receptor T cells in treating high-grade gliomas in adult and pediatric populations. Immunotherapy 15 (5) (2023)
Pauline Wils, Laurent Peyrin-Biroulet
Etrasimod for the treatment of ulcerative colitis. Immunotherapy 15 (5) (2023)
Arman Kalami, Mehdi Shahgolzari, Ahmad Yari Khosroushahi, Steven Fiering
Combining in situ vaccination and immunogenic apoptosis to treat cancer. Immunotherapy 15 (5) (2023)
Xueyin Zhou, Jiasheng Cao, Win Topatana, Tian-Ao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanic, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Shen, Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis. Immunotherapy 15 (5) (2023)
Arman Kalami, Mehdi Shahgolzari, Ahmad Yari Khosroushahi, Steven Fiering
Combining in situ vaccination and immunogenic apoptosis to treat cancer. Immunotherapy 15 (5) (2023)
Nicolina Jovanovich, Ahmed Habib, Nu Farrukh Hameed, Lincoln Edwards, Pascal O Zinn
Applications and current challenges of chimeric antigen receptor T cells in treating high-grade gliomas in adult and pediatric populations. Immunotherapy 15 (5) (2023)
Mateus de Oliveira Taveira, Milton José de Barros E Silva, Paula Nicole Vieira Pinto Barbosa
Imaging-calculated splenic volume is associated with response in melanoma patients treated with immunotherapy. Immunotherapy 15 (5) (2023)
Xiaoyan Chen, Wenjie Shi
An unusual case of immune-related gastritis in one patient receiving toripalimab therapy. Immunotherapy 15 (5) (2023)
Xueyin Zhou, Jiasheng Cao, Win Topatana, Tian-Ao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanic, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Shen, Ming-Yu Chen
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis. Immunotherapy 15 (5) (2023)

volume 15, number 7, 2023

Nina Beri
Immune checkpoint inhibitors in cholangiocarcinoma. Immunotherapy 15 (7) (2023)
Nina Beri
Immune checkpoint inhibitors in cholangiocarcinoma. Immunotherapy 15 (7) (2023)
Nina Beri
Immune checkpoint inhibitors in cholangiocarcinoma. Immunotherapy 15 (7) (2023)
Pedro Luiz Serrano UsÓn Junior, Tanios Bekaii-Saab
Moving beyond single-agent checkpoint inhibition in biliary tract cancers: what is the next frontier? Immunotherapy 15 (7) (2023)
Pedro Luiz Serrano UsÓn Junior, Tanios Bekaii-Saab
Moving beyond single-agent checkpoint inhibition in biliary tract cancers: what is the next frontier? Immunotherapy 15 (7) (2023)
Pedro Luiz Serrano UsÓn Junior, Tanios Bekaii-Saab
Moving beyond single-agent checkpoint inhibition in biliary tract cancers: what is the next frontier? Immunotherapy 15 (7) (2023)

volume 15, number 8, 2023

Jake Robert Thompson, Julia Lai-Kwon, Rachael Lisa Morton, Alexander D Guminski, Maria Gonzalez, Victoria Atkinson, Shahneen Sandhu, Michael P Brown, Alexander M Menzies, Grant A McArthur, Serigne N Lô, Georgina V Long, Iris Bartula
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy. Immunotherapy 15 (8) (2023)
Jake Robert Thompson, Julia Lai-Kwon, Rachael Lisa Morton, Alexander D Guminski, Maria Gonzalez, Victoria Atkinson, Shahneen Sandhu, Michael P Brown, Alexander M Menzies, Grant A McArthur, Serigne N Lô, Georgina V Long, Iris Bartula
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy. Immunotherapy 15 (8) (2023)
Jake Robert Thompson, Julia Lai-Kwon, Rachael Lisa Morton, Alexander D Guminski, Maria Gonzalez, Victoria Atkinson, Shahneen Sandhu, Michael P Brown, Alexander M Menzies, Grant A McArthur, Serigne N Lô, Georgina V Long, Iris Bartula
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy. Immunotherapy 15 (8) (2023)

volume 15, number 9, 2023

Yang Zhou, Guo-Hong Zheng, Na Li, Jing-Jing Liu, Xiao-Hong Wang, Yu-Feng Li
Fatal cytokine-release syndrome in a patient receiving toripalimab: a case report. Immunotherapy 15 (9) (2023)
Yang Zhou, Guo-Hong Zheng, Na Li, Jing-Jing Liu, Xiao-Hong Wang, Yu-Feng Li
Fatal cytokine-release syndrome in a patient receiving toripalimab: a case report. Immunotherapy 15 (9) (2023)
Maryam Noori, Farimah Fayyaz, Nima Rezaei
Impact of Helicobacter pylori infection on the efficacy of immune checkpoint inhibitors for cancer treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Spiros Tzivelekis, Jordan Orange, Christine Poulos, Lisa M Meckley, Holly L Peay, Jessie Sutphin, Vivian P Hernandez-Trujillo, Richard L Wasserman
Development of a novel shared decision making aid for primary immunodeficiency diseases. Immunotherapy 15 (9) (2023)
Yang Zhou, Guo-Hong Zheng, Na Li, Jing-Jing Liu, Xiao-Hong Wang, Yu-Feng Li
Fatal cytokine-release syndrome in a patient receiving toripalimab: a case report. Immunotherapy 15 (9) (2023)
Tianlong Ding, Yang Yu, Xiaoyuan Pan, Hao Chen
Establishment of humanized mice and its application progress in cancer immunotherapy. Immunotherapy 15 (9) (2023)
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, Ya-Fei Yang, Lun-Jie Yan, Zi-Niu Ding, Jun-Shuai Xue, Long-Shan Yang, Yu-Chuan Yan, Zhao-Ru Dong, Dong-Xu Wang, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Tianlong Ding, Yang Yu, Xiaoyuan Pan, Hao Chen
Establishment of humanized mice and its application progress in cancer immunotherapy. Immunotherapy 15 (9) (2023)
Tianlong Ding, Yang Yu, Xiaoyuan Pan, Hao Chen
Establishment of humanized mice and its application progress in cancer immunotherapy. Immunotherapy 15 (9) (2023)
Angioletta Lasagna, Paolo Pedrazzoli, Raffaele Bruno, Paolo Sacchi
Postvaccination immune-mediated hepatitis: what do we really know? Immunotherapy 15 (9) (2023)
Angioletta Lasagna, Paolo Pedrazzoli, Raffaele Bruno, Paolo Sacchi
Postvaccination immune-mediated hepatitis: what do we really know? Immunotherapy 15 (9) (2023)
Maryam Noori, Farimah Fayyaz, Nima Rezaei
Impact of Helicobacter pylori infection on the efficacy of immune checkpoint inhibitors for cancer treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Maryam Noori, Farimah Fayyaz, Nima Rezaei
Impact of Helicobacter pylori infection on the efficacy of immune checkpoint inhibitors for cancer treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Spiros Tzivelekis, Jordan Orange, Christine Poulos, Lisa M Meckley, Holly L Peay, Jessie Sutphin, Vivian P Hernandez-Trujillo, Richard L Wasserman
Development of a novel shared decision making aid for primary immunodeficiency diseases. Immunotherapy 15 (9) (2023)
Maryam Noori, Farimah Fayyaz, Nima Rezaei
Impact of Helicobacter pylori infection on the efficacy of immune checkpoint inhibitors for cancer treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Angioletta Lasagna, Paolo Pedrazzoli, Raffaele Bruno, Paolo Sacchi
Postvaccination immune-mediated hepatitis: what do we really know? Immunotherapy 15 (9) (2023)
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, Ya-Fei Yang, Lun-Jie Yan, Zi-Niu Ding, Jun-Shuai Xue, Long-Shan Yang, Yu-Chuan Yan, Zhao-Ru Dong, Dong-Xu Wang, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, Ya-Fei Yang, Lun-Jie Yan, Zi-Niu Ding, Jun-Shuai Xue, Long-Shan Yang, Yu-Chuan Yan, Zhao-Ru Dong, Dong-Xu Wang, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Spiros Tzivelekis, Jordan Orange, Christine Poulos, Lisa M Meckley, Holly L Peay, Jessie Sutphin, Vivian P Hernandez-Trujillo, Richard L Wasserman
Development of a novel shared decision making aid for primary immunodeficiency diseases. Immunotherapy 15 (9) (2023)